Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.

Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O'Donovan D, Ramos R, Maier HJ, Masood A, Thieblemont C, Schuster SJ

Open source

DOI: 10.1182/blood.2023021567
Published: 2024 Apr 25
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2023021567,
  title = {Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.},
  author = {Dreyling M and Fowler NH and Dickinson M and Martinez-Lopez J and Kolstad A and Butler J and Ghosh M and Popplewell L and Chavez JC and Bachy E and Kato K and Harigae H and Kersten MJ and Andreadis C and Riedell PA and Ho PJ and Pérez-Simón JA and Chen AI and Nastoupil LJ and von Tresckow B and María Ferreri AJ and Teshima T and Patten PEM and McGuirk JP and Petzer AL and Offner F and Viardot A and Zinzani PL and Malladi R and Paule I and Zia A and Awasthi R and Han X and Germano D and O'Donovan D and Ramos R and Maier HJ and Masood A and Thieblemont C and Schuster SJ},
  year = {2024},
  journal = {Blood},
  doi = {10.1182/blood.2023021567},
  url = {https://doi.org/10.1182/blood.2023021567}
}

RIS

TY  - JOUR
TI  - Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
AU  - Dreyling M
AU  - Fowler NH
AU  - Dickinson M
AU  - Martinez-Lopez J
AU  - Kolstad A
AU  - Butler J
AU  - Ghosh M
AU  - Popplewell L
AU  - Chavez JC
AU  - Bachy E
AU  - Kato K
AU  - Harigae H
AU  - Kersten MJ
AU  - Andreadis C
AU  - Riedell PA
AU  - Ho PJ
AU  - Pérez-Simón JA
AU  - Chen AI
AU  - Nastoupil LJ
AU  - von Tresckow B
AU  - María Ferreri AJ
AU  - Teshima T
AU  - Patten PEM
AU  - McGuirk JP
AU  - Petzer AL
AU  - Offner F
AU  - Viardot A
AU  - Zinzani PL
AU  - Malladi R
AU  - Paule I
AU  - Zia A
AU  - Awasthi R
AU  - Han X
AU  - Germano D
AU  - O'Donovan D
AU  - Ramos R
AU  - Maier HJ
AU  - Masood A
AU  - Thieblemont C
AU  - Schuster SJ
PY  - 2024
JO  - Blood
DO  - 10.1182/blood.2023021567
UR  - https://doi.org/10.1182/blood.2023021567
ER  -

APA

M, D., NH, F., M, D., J, M., A, K., J, B., M, G., L, P., JC, C., E, B., K, K., H, H., MJ, K., C, A., PA, R., PJ, H., JA, P., AI, C., LJ, N., B, V. T., AJ, M. F., T, T., PEM, P., JP, M., AL, P., F, O., A, V., PL, Z., R, M., I, P., A, Z., R, A., X, H., D, G., D, O., R, R., HJ, M., A, M., C, T., & SJ, S. (2024). Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.. Blood. https://doi.org/10.1182/blood.2023021567

Source records

pubmed · retrieved 2026-11-10T18:02:29.313Z